AlJazira Capital issues Q3 2025 profit forecasts

02/10/2025 Argaam Special


AlJazira Capital issued Q3 2025 earnings forecasts for a number of Saudi banks and companies under its coverage.

 

It expects Al Rajhi Bank to report a net profit of SAR 6 billion in the three-month period, an increase of 18% year-on-year (YoY).

 

AlJazira Capital's Q3 2025 Earnings Forecasts (SAR mln)

Company

Q3 2025

(projected)

YoY Change

Energy

Arabian Drilling

9

(89%)

ADES

198

(1%)

Banking

Al Rajhi Bank

6029

+18%

Alinma Bank

1519

(3%)

Bank Albilad

735

+5%

Telecoms

stc

3,421

(26%)

Mobily

831

+0.3%

Zain KSA

123

(18%)

Materials

SABIC

1159

+15%

Tasnee

31.0

(65%)

Yansab

67.4

(48%)

SABIC AN

1278.7

+55%

Sipchem

38.9

(62%)

Advanced

51.1

+12%

Saudi Kayan

(401.1)

--

Alujain

26.1

(43%)

Maaden

2305.6

+137%

Cement

Yamama Cement

77.3

(21%)

Saudi Cement

60.8

(39%)

Southern Cement

18.5

(65%)

Qassim Cement

48.8

(33%)

Arabian Cement

20.1

(56%)

Yanbu Cement

14.2

(54%)

City Cement

17.2

(49%)

Eastern Cement

35.3

(14%)

Riyadh Cement

36.5

(61%)

Healthcare

Al Hammadi

75.3

(5%)

Mouwasat

188.2

+26%

Care

89.9

+49%

Dallah

128.9

+2%

Sulaiman Al Habib

634.1

+6%

Saudi German Health

69.3

+12%

Almoosa

59.5

+113%

Fakeeh Care

71.7

(23%)

Consumer Staples Retailing

Al Othaim

36.1

(52%)

BinDawood Holding

41.5

+25%

Almunajem

30.6

(24%)

Retailing

Jarir

327.5

+6%

SACO

52.3

--

eXtra

141.6

(9%)

Americana

195.4

+39%

Consumer Services

Seera

60.7

+98%

Leejam

105.1

(44%)

Other Sectors

Almarai

616.4

+8%

Modern Mills

54.9

+13%

Tanmiah

3.8

(84%)

Budget Saudi

88.5

+23%

Theeb

49.1

+6%

Lumi

49.7

+24%

SAL

160.8

+3%

flynas

173.0

+65%

SGS

93.1

+14%

CATRION

76.1

(31%)

Al Mawarid

34.1

+99%

Elm

611.2

+23%

solutions

443.2

(4%)

2P

38.5

+4%

Alkhorayef Water

66.0

+64%

Riyadh Cables

265.6

+13%

Astra

141

+1%

Almajed Oud

27.8

+24%

Saudi Tadawul Group

89.5

(36%)

TASHEEL

70.2

+19%

Jamjoom Pharma

117.3

+23%

Avalon Pharma

16.0

+313%

 

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.